1183 related articles for article (PubMed ID: 15383792)
1. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.
Adam R; Delvart V; Pascal G; Valeanu A; Castaing D; Azoulay D; Giacchetti S; Paule B; Kunstlinger F; Ghémard O; Levi F; Bismuth H
Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792
[TBL] [Abstract][Full Text] [Related]
2. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?
Adam R; Pascal G; Castaing D; Azoulay D; Delvart V; Paule B; Levi F; Bismuth H
Ann Surg; 2004 Dec; 240(6):1052-61; discussion 1061-4. PubMed ID: 15570210
[TBL] [Abstract][Full Text] [Related]
3. Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy.
Nuzzo G; Giuliante F; Ardito F; Vellone M; Pozzo C; Cassano A; Giovannini I; Barone C
J Gastrointest Surg; 2007 Mar; 11(3):318-24. PubMed ID: 17458605
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
5. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
[TBL] [Abstract][Full Text] [Related]
6. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
Pak LM; Kemeny NE; Capanu M; Chou JF; Boucher T; Cercek A; Balachandran VP; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
J Surg Oncol; 2018 Mar; 117(4):634-643. PubMed ID: 29165816
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.
DʼAngelica MI; Correa-Gallego C; Paty PB; Cercek A; Gewirtz AN; Chou JF; Capanu M; Kingham TP; Fong Y; DeMatteo RP; Allen PJ; Jarnagin WR; Kemeny N
Ann Surg; 2015 Feb; 261(2):353-60. PubMed ID: 24646562
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial.
Gruenberger T; Bridgewater J; Chau I; García Alfonso P; Rivoire M; Mudan S; Lasserre S; Hermann F; Waterkamp D; Adam R
Ann Oncol; 2015 Apr; 26(4):702-708. PubMed ID: 25538173
[TBL] [Abstract][Full Text] [Related]
10. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
Masi G; Cupini S; Marcucci L; Cerri E; Loupakis F; Allegrini G; Brunetti IM; Pfanner E; Viti M; Goletti O; Filipponi F; Falcone A
Ann Surg Oncol; 2006 Jan; 13(1):58-65. PubMed ID: 16372158
[TBL] [Abstract][Full Text] [Related]
11. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
[TBL] [Abstract][Full Text] [Related]
12. OncoSurge: a strategy for long-term survival in metastatic colorectal cancer.
Alberts S; Poston G
Colorectal Dis; 2003 Nov; 5 Suppl 3():20-8. PubMed ID: 23573557
[TBL] [Abstract][Full Text] [Related]
13. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.
Bismuth H; Adam R; Lévi F; Farabos C; Waechter F; Castaing D; Majno P; Engerran L
Ann Surg; 1996 Oct; 224(4):509-20; discussion 520-2. PubMed ID: 8857855
[TBL] [Abstract][Full Text] [Related]
14. Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.
Lévi FA; Boige V; Hebbar M; Smith D; Lepère C; Focan C; Karaboué A; Guimbaud R; Carvalho C; Tumolo S; Innominato P; Ajavon Y; Truant S; Castaing D; De Baere T; Kunstlinger F; Bouchahda M; Afshar M; Rougier P; Adam R; Ducreux M;
Ann Oncol; 2016 Feb; 27(2):267-74. PubMed ID: 26578731
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.
Giacchetti S; Itzhaki M; Gruia G; Adam R; Zidani R; Kunstlinger F; Brienza S; Alafaci E; Bertheault-Cvitkovic F; Jasmin C; Reynes M; Bismuth H; Misset JL; Lévi F
Ann Oncol; 1999 Jun; 10(6):663-9. PubMed ID: 10442188
[TBL] [Abstract][Full Text] [Related]
16. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
Goéré D; Deshaies I; de Baere T; Boige V; Malka D; Dumont F; Dromain C; Ducreux M; Elias D
Ann Surg; 2010 Apr; 251(4):686-91. PubMed ID: 20224373
[TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
[TBL] [Abstract][Full Text] [Related]
18. FOLFOX enables high resectability and excellent prognosis for initially unresectable colorectal liver metastases.
Beppu T; Hayashi N; Masuda T; Komori H; Horino K; Hayashi H; Okabe H; Baba Y; Kinoshita K; Akira C; Watanebe M; Takamori H; Baba H
Anticancer Res; 2010 Mar; 30(3):1015-20. PubMed ID: 20393029
[TBL] [Abstract][Full Text] [Related]
19. Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.
Knowles B; Welsh FK; Chandrakumaran K; John TG; Rees M
HPB (Oxford); 2012 May; 14(5):298-309. PubMed ID: 22487067
[TBL] [Abstract][Full Text] [Related]
20. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA
Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
